Medicines Evaluation Unit Revenue and Competitors
Estimated Revenue & Valuation
- Medicines Evaluation Unit's estimated annual revenue is currently $26.7M per year.
- Medicines Evaluation Unit's estimated revenue per employee is $201,000
Employee Data
- Medicines Evaluation Unit has 133 Employees.
- Medicines Evaluation Unit grew their employee count by 6% last year.
Medicines Evaluation Unit's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Marketing Manager | Reveal Email/Phone |
2 | Senior Research Scientist | Reveal Email/Phone |
3 | Analytical Scientist | Reveal Email/Phone |
Medicines Evaluation Unit Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is Medicines Evaluation Unit?
The Medicines Evaluation Unit (MEU) Ltd, is one of the UK's leading contract research organisations, a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, within a state-of-the-art hospital-based research facility, allied with fast volunteer recruitment rates, enables MEU to offer clients positive clinical trial solutions. The MEU's core skill area is in respiratory clinical trials, together with early phase exploratory studies. This is enhanced by the specialist support offered by collaboration with the University Hospital of South Manchester, and its extensive facilities. The MEU specialises in performing clinical trials (from Phase I through to IV) in respiratory / inflammatory medicine and related areas.
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
133
Number of Employees
$26.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medicines Evaluation Unit News
This placebo-controlled Phase 1/2 study in Japan evaluated the safety and ... In addition, Takeda has joined the Innovative Medicines...
... interim director of medicines evaluation at NICE, said in a release. ... Johnson & Johnson drops out of the race for Pfizer consumer unit,...
For more information about the Phase 1b/2 study evaluating Annamycin for ... at the Medicines Evaluation Unit in Manchester, United Kingdom.
Other Companies in Manchester
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 133 | 5% | N/A |
#2 | $20M | 133 | 7% | N/A |
#3 | $28.1M | 134 | -1% | N/A |
#4 | $31.4M | 134 | 3% | N/A |
#5 | $33.2M | 135 | -27% | N/A |
